{
  "docId": "019dd923-5e88-73ef-bd5d-01cf0d8a8fbc",
  "docSlug": "cc8183ec02431b7a",
  "documentTitle": "2022 Air Street Capital The State of AI Report 2022",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 63,
  "pageCount": 114,
  "prevPage": 62,
  "nextPage": 64,
  "slideType": "industry_trends",
  "function": "quantify_impact",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "The slide uses a stacked bar chart for company-specific pipelines and a horizontal bar chart for the aggregate percentage distribution of assets.",
  "elementsJson": [
    "headline_text",
    "bar_chart_stacked",
    "bar_chart_horizontal"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc/63",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc#slide-63",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "And many more assets in early discovery stages. We expect early clinical trial readouts from 2023 onwards.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a219-b14f8c8790ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.4,
        "x": 0.55,
        "y": 0.35
      },
      "kind": "chart",
      "text": "% of assets per pipeline stage overall",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "498600d8-68e1-4e3d-bbf5-8b83713f5454",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "# of assets per pipeline stage per company",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4447c806-9fb1-44ea-9729-8ffc8f3c8fde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Number of assets in clinical trials: 18",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a219-b5aecbf8eccb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "And many more assets in early discovery stages. We expect early clinical trial readouts from 2023 onwards.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c0e70ee-7dcf-4af6-bb6b-7d03b06a2c44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Updated as of 26 Aug 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cd67f51-0625-48fe-9ad9-9541c3cddb29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "title",
      "text": "AI-first drug discovery companies have 18 assets in clinical trials, up from 0 in 2020",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14e4ed3f-4a62-4a59-994d-d7327e62af59",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "e6ae5228-fd29-40f5-b397-3e0c80ee59c0",
      "evidence": "The slide mentions various charts (bar, line, stacked) implying a selection of charts to display data.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 80,
      "from": 5,
      "beatId": "019dd95a-0682-776c-8e35-2557e3799e96",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Definitions, exec summary, Research and Industry sections inventory the state of AI.",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 93,
      "from": 11,
      "beatId": "019dd95a-0682-776c-8e35-35abf646aa8b",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Rising Action",
      "beatSlug": "mountain-rising-action",
      "evidence": "Research, Industry, Politics sections accumulate signals.",
      "position": 2,
      "confidence": 55,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 69,
      "from": 62,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3d-c1bcbf6f888c",
      "evidence": "Copilot, AI-first drug pipelines, CE-mark imaging, UK university spinouts, Stanford/Berkeley programmes.",
      "position": 11,
      "objective": "Inventory commercial AI applications: code, drug discovery, diagnostics, spinouts",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 72,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}